The Role of Hypoxia-Inducible Factor-1α, Glucose Transporter-1, (GLUT-1) and Carbon Anhydrase IX in Endometrial Cancer Patients

Table 1

Baseline characteristics of endometrial cancer patients.

	𝑁 (%)
FIGO stage
IA	27 (29,35%)
IB	18 (19,57%)
II	14 (15,22%)
IIIA	10 (10,87%)
IIIC	17 (18,48%)
IVB	6 (6,52%)
Grading
G1	7 (7,61%)
G2	66 (71,74%)
G3	19 (20,65%)
Bokhman subtype
Endometrioid	70 (76,09%)
Nonendometrioid	22 (23,91%)
Lymph node metastases (N)
Absent N0	69 (75%)
Present N1	23 (25%)
Distant metastases (M)
Absent M0	86 (93,48%)
Present M1	6 (6,52%)
Myometrial invasion
<50%	56 (60,87%)
≥50%	36 (39,13%)
Cervical involvement
Absent	54 (58,70%)
Present	38 (41,30%)
Adnexal Involvement
Absent	81 (88,04%)
Present	11 (11,96%)